QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PATIENTS WITH RHEUMATOID ARTHRITIS 期刊论文 ANNALS OF THE RHEUMATIC DISEASES, 2019, 卷号: 78 作者:  Qiu, Wenting;  Chai, Katherine;  Guo, Xinjun;  Zhang, Xin;  Liu, Eugene 收藏  |  浏览/下载：60/0  |  提交时间：2019/12/04 A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文 ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01 作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan 收藏  |  浏览/下载：45/0  |  提交时间：2020/01/03 A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 期刊论文 2019, 卷号: 78, 页码: 1140-1140 作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan 收藏  |  浏览/下载：41/0  |  提交时间：2020/01/03 骨关节炎分类标准和评估工具的概况性系统评价 期刊论文 2019, 卷号: 23, 期号: 2, 页码: 82-88 作者:  黄慈波;  杨楠;  张志毅;  陈颖娟;  叶志中 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 骨关节炎  分类  诊断  概况性系统评价